Interpretable machine learning-driven QSAR modeling for coagulation factor X inhibitors: from molecular descriptors to predictive potency
Author:
Top Cited Papers
Open Access
- 23 January 2026
- journal article
- Published by Springer Nature in Journal of Computer-Aided Molecular Design
- Vol. 40 (1) , 53
Abstract
Inhibition of Coagulation Factor X (FXa) is a clinically validated therapeutic strategy; however, developing safer and more selective inhibitors remains a major challenge. In this study, we developed an interpretable machine learning–based QSAR framework to predict both the inhibitory potency and activity class of small molecules targeting FXa. A structurally curated dataset of 6400 compounds was retrieved from ChEMBL, standardized, and encoded using 391 non-redundant Mordred descriptors following systematic filtering. Benchmarking of 42 regression and 42 classification algorithms identified ExtraTreesRegressor and XGBoostClassifier as the most robust models. The regression model achieved an R 2 of 0.760 and an RMSE of 0.831 on the independent test set, while the classification model reached an accuracy of 0.91 with balanced precision, recall, and an ROC-AUC of 0.962. SHAP (SHapley Additive exPlanations) analysis further enhanced interpretability by revealing that electrostatic, topological, and polar surface descriptors were the dominant contributors to FXa inhibitory potency. Applicability domain assessment using Williams plots confirmed that most compounds in both the training and test sets lay within the model’s reliable prediction space. Overall, the proposed QSAR pipeline integrates strong predictive performance with valuable mechanistic interpretability and rigorous validation, offering a practical computational tool for the virtual screening and rational design of novel FXa inhibitors.Keywords
All Related Versions
Funding Information
- Akdeniz University
This publication has 31 references indexed in Scilit:
- Comparison of Different Approaches to Define the Applicability Domain of QSAR ModelsMolecules, 2012
- Profiling the Structural Determinants for the Selectivity of Representative Factor-Xa and Thrombin Inhibitors Using Combined Ligand-Based and Structure-Based ApproachesJournal of Chemical Information and Modeling, 2011
- Developments in factor Xa inhibitors for the treatment of thromboembolic disordersMedicinal Research Reviews, 2011
- Prediction of factor Xa inhibitors by machine learning methodsJournal of Molecular Graphics and Modelling, 2007
- QSAR Applicability Domain Estimation by Projection of the Training Set in Descriptor Space: A ReviewAlternatives to Laboratory Animals, 2005
- Probing the Subpockets of Factor Xa Reveals Two Binding Modes for Inhibitors Based on a 2-Carboxyindole Scaffold: A Study Combining Structure-Activity Relationship and X-ray CrystallographyJournal of Medicinal Chemistry, 2005
- Structural Requirements for Factor Xa Inhibition by 3-Oxybenzamides with Neutral P1 Substituents: Combining X-ray Crystallography, 3D-QSAR, and Tailored Scoring FunctionsJournal of Medicinal Chemistry, 2005
- Current Status of Methods for Defining the Applicability Domain of (Quantitative) Structure-Activity RelationshipsAlternatives to Laboratory Animals, 2005
- Current trends in quantitative structure activity relationships on FXa inhibitors: Evaluation and comparative analysisMedicinal Research Reviews, 2004
- Design and Quantitative Structure−Activity Relationship of 3-Amidinobenzyl-1H-indole-2-carboxamides as Potent, Nonchiral, and Selective Inhibitors of Blood Coagulation Factor XaJournal of Medicinal Chemistry, 2002